Alterations of cell cycle regulating proteins: Rb, p21 and p16 in laryngeal cancer;Zaburzenia białek regulatorowych cyklu komórkowego: Rb, p21 i p16 w raku krtani

Otolaryngologia Polska

Volumn 61, Issue 6, 2007, Pages 951-957

  Pietruszewska, Wioletta ^a   Durko, Marcin ^a   Kobos, Józef ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UM w odzi   (Poland)

Author keywords

Cell cycle; Laryngeal cancer; p16 protein; p21 protein; p53 protein; Prognostic factor; Rb protein

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; P16 PROTEIN, HUMAN; RETINOBLASTOMA PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CELL CYCLE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX TUMOR; MALE; METABOLISM; MIDDLE AGED; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 38049065107     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0030-6657(07)70559-0     Document Type: Article

References (17)

1. Bazan V, Zanna I, Migliavacca M, Sanz-Casla MT, Maestro ML, Corsale S, i wsp. Prognostic significance of p161NK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma. J Cell Physiol 2002; 192(3): 286-293.
2. Belinsky SA, Nikula KJ, Palmisano WA. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarkers of early diagnosis. Proc Natl Acad Sci USA 1998; 95: 11891-11896.
3. Bertram JS: The molecular biology of cancer. Mol Aspects Med 2000; 21: 167-223.
4. El-Naggar AK, Lai S, Clayman GL, Zhou JH, Tucker SA, Myers J, i wsp. Expression of p16, Rb, and Cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. Human Pathol 1999; 30(9): 1013-1018.
5. Feakins RM, Nickols CD, Bidd H, Walton SJ. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival. Human Pathol 2003; 34(12): 1276-1282.
6. Gruttgen A, Reichenzeller M, Junger M. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers. J. Pathol 2002; 194: 311-317.
7. Hirvikoski P, Virtaniemi J, Kumpulainen E, Johansson R, Kosma VM. Supraglottic and glottic carcinomas. clinically and biologically distinct entities? Eur J Cancer 2002; 38(13): 1717-1123.
8. Jeannon JP, Soames J, Lunec J, Awwad S, Ashton V, Wilson JA. Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal cancer. Clin Otolaryngol 2000; 25(1): 23-27.
9. Michalides RJ. Cell cycle regulators: mechanisms and their role in aethiology, prognosis, and treatment of cancer. J Clin Pathol 1999; 52: 555-568.
10. Miracca EC, Kowalski LP, Nagai MA. High prevalence of p16 genetic alterations in head and neck tumours. Br J Cancer 1999; 81(4): 677-683.
11. Pruneri G, Pignataro L, Carboni N, Buffa R, Di Finizio D, Cesana BM, i wsp. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer. J Clin Oncol 1999; 17(10): 3150-3159.
12. Rassidakis GZ, Lai R, Herling M, Cromwell C, Schmitt-Graeff A, Medeiros LJ. Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma. Am J Pathol 2004; 164(6): 2259-2267.
13. Sartor M, Steingrimsdottir H, Elamin F, Gaken J, Warnakulasuriya S, Partridge M, i wsp. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. British J Cancer 1999; 80(1/2): 79-86.
14. Volasek M, Bracko M, Gale N. Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions. J Laryngol Otol 2003; 117(4): 286-293.
15. Yoo GH, Xu HJ, Brennan JA, Westra W, Hruban RH, Koch W, i wsp. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994; 54(1): 4603-4606.
16. Yuen PW, Chow V, Choy J, Lam KY, Ho WY, Wei WI. Clinicopathological significance of p53 and p21 expression in the surgical treatment of laryngeal carcinoma. Anticancer Res 2000; 20(6C): 4863-4866.
17. Yuen PW, Man M, Lam KY, Kwong YL. Clinicopathological of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 2002; 55(1): 58-60.